A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo

Inflammation Research

Volumn 55, Issue 6, 2006, Pages 241-244

  Popov, T A ^a   Dumitrascu, D ^b   Bachvarova, A ^a   Bocsan, C ^b   Dimitrov, V ^a   Church, M K ^c  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b BABE BOLYAI UNIVERSITY   (Romania)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Desloratadine; Histamine; Levocetirizine; Skin; Wheal and flare reaction

Indexed keywords

DESLORATADINE; HISTAMINE; LEVOCETIRIZINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM; HUMAN; IN VIVO STUDY; MALE; MOTOR DYSFUNCTION; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SKIN; URTICARIA; VISUAL ANALOG SCALE;

ADULT; CETIRIZINE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HISTAMINE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LORATADINE; MALE; MIDDLE AGED; PIPERAZINES; SKIN; SKIN TESTS; URTICARIA;

EID: 33748511196     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-0075-z     Document Type: Article

References (19)

1. Lowman MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils and intestinal mucosa in response to IgE-dependent and non-immunological stimuli. J Allergy Clin Immunol 1988; 81: 590-7.
2. Lowman MA, Benyon RC, Church MK. Characterization of neuropeptide-induced histamine released from human dispersed skin mast cells. Br J Pharmacol 1988; 95: 121-30.
3. Caulfield JP, El-Lati S, Thomas G, Church MK. Dissociated human foreskin mast cells degranulate in response to Anti IgE and Substance P. Laboratory Investigation 1990; 63: 502-10.
4. Okayama Y, Ono Y, Nakazawa T, Church MK, Mori M. Human skin mast cells produce TNF-alpha by substance P. Int Arch Allergy Immunol 1998; 117 Suppl 1: 48-51.
5. Petersen LJ, Church MK, Skov PS. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: A microdialysis study. Clin Exp Allergy 1997; 27: 284-95.
6. Denham KJ, Boutsiouki P, Clough GF, Church MK. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 2003; 52: 424-7.
7. Purohit A, Melac M, Pauli G, Frossard N. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol 2003; 56: 388-94.
8. Passalacqua G, Guerra L, Compalati E, Massacane P, Rogkakou A, Zanella C et al. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. Int Arch Allergy Immunol 2004; 135: 143-7.
9. Bousquet J, van Cauwenberge P, Bachert C, Canonica GW, Demoly P, Durham SR et al. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy 2003; 58: 192-7.
10. Black AK, Greaves MW. Antihistamines in urticaria and angioedema. Clin Allergy Immunol 2002; 17: 249-86.
11. Greaves MW, Davies MG. Histamine receptors in human skin: indirect evidence. Br J Dermatol 1982; 107 Suppl 23: 101-5.
12. Gillard M, Van der PC, Massingham R, Chatelain P. Binding characteristics of [3H]levocetirizine to cloned human H1-histamine receptors expressed in CHO cells. Inflamm Res 2002; 51 Suppl 1: S77-8.
13. 1-antagonists: receptor affinity versus selectivity. Inflamm Res 2003; 52 Suppl 1: S49-50.
14. Molimard M, Diquet B, Benedetti MS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004; 18: 399-411.
15. Affrime M, Gupta S, Banfield C, Cohen A. A pharmacokinetic profile of desloratadine in healthy adults, including elderly. Clin Pharmacokinet 2002; 41 Suppl 1: 13-9.
16. Gillard M, Benedetti MS, Chatelain P, Baltes E. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54: 367-9.
17. Verster JC, de Weert AM, Bijtjes SI, Aarab M, van Oosterwijck AW, Eijken EJ et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) 2003; 169: 84-90.
18. Vuurman EF, Rikken GH, Muntjewerff ND, de Halleux F, Ramaekers JG. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol 2004; 60: 307-13.
19. Verster JC, Volkerts ER, van Oosterwijck AW, Aarab M, Bijtjes SI, de Weert AM et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 2003; 111: 623-7.